Literature DB >> 1854607

ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea.

Y Yura1, M Azuma, K Uchida, H Momose, R Oyasu.   

Abstract

We have established a reliable method to induce invasive and non-invasive carcinomas in the heterotopically transplanted urinary bladder of rats by repeated injection of N-methyl-N-nitrosourea (MNU), and examined the alterations of the ras oncogenes and ras oncogene product (p21) in the induced tumours. The incidence of muscle-invasive carcinomas was proportional to the total dose of MNU. When 5, 6 or 12 doses of MNU were used, muscle invasive carcinomas developed in 22, 58 or 45% of animals, respectively, after a mean observation period, respectively, of 54 +/- 9, 45 +/- 13 and 38 +/- 3 weeks. Whereas activated H-ras gene was detected in only one non-invasive carcinoma by DNA transfection assay, seven of 18 non-invasive and invasive carcinomas showed activated ras p21 when examined by immunoblot analysis. Amplification or rearrangement of myc or epidermal growth factor (EGF) receptor gene was not observed. The results indicate that alterations of ras gene may be involved in the development of rat bladder carcinomas but not of invasiveness.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854607      PMCID: PMC1977327          DOI: 10.1038/bjc.1991.231

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Monoclonal antibody specific for an activated RAS protein.

Authors:  W P Carney; D Petit; P Hamer; C J Der; T Finkel; G M Cooper; M Lefebvre; H Mobtaker; R Delellis; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats.

Authors:  M Debiec-Rychter; K Zukowski; C Y Wang
Journal:  J Natl Cancer Inst       Date:  1989-03-01       Impact factor: 13.506

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Biological properties of human c-Ha-ras1 genes mutated at codon 12.

Authors:  P H Seeburg; W W Colby; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Nov 1-7       Impact factor: 49.962

5.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

6.  Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.

Authors:  J Fujita; S K Srivastava; M H Kraus; J S Rhim; S R Tronick; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea.

Authors:  M Azuma; H Momose; R Oyasu
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

8.  Induction of high-grade, high-stage carcinomas in the rat urinary bladder.

Authors:  R Oyasu; S Samma; S Ozono; K Bauer; C B Wallemark; Y Homma
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

9.  Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21.

Authors:  T Finkel; C J Der; G M Cooper
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

10.  Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants.

Authors:  F J Meyers; P H Gumerlock; S P Kokoris; R W deVere White; F McCormick
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.